Brief: Diamyd Trial In Lada Published In Scientific Journal

Diamyd Medical AB

17/08/2023 07:37

Aug 17 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * RESULTS FROM DIAMYD® ANTIGEN-SPECIFIC IMMUNOTHERAPY TRIAL
IN
LADA PUBLISHED IN SCIENTIFIC JOURNAL
    * TREATMENT WITH DIAMYD OF INDIVIDUALS UP TO 70 YEARS OF AGE
DIAGNOSED WITH LADA, WAS SAFE AND SHOWED DISEASE MODIFYING
POTENTIAL
    * EVALUATING REGULATORY PATHWAYS AND POSSIBLE PARTNERSHIPS
TO
BRING THIS PIVOTAL THERAPY TO LADA PATIENTS
    * NO TREATMENT-RELATED SEVERE ADVERSE EVENTS WERE REPORTED

Source text for Eikon:  ID:nWkr4Lbk9J 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))